Crystal Tang

SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo

Stephen K Burley, Spencer Emtage, Shane Atwell, 2009, Molecular Cancer Therapeutics.

Inhibition of T315I Bcr-Abl and Other Imatinib-Resistant Bcr-Abl Mutants by the Selective Abl Kinase Inhibitor SGX70393.

S. Burley, A. Corbin, M. Deininger, 2006 .

In vitro and in vivo antitumor activities of SGX523, a novel MET inhibitor

S. Burley, Marshall C. Peterman, K. Froning, 2007 .

DNA replication machinery prevents Rad52-dependent single-strand annealing that leads to gross chromosomal rearrangements at centromeres

H. Niki, Keita Aoki, T. Nakagawa, 2020, Communications Biology.

DNA replication machinery prevents Rad52-dependent single-strand annealing that leads to gross chromosomal rearrangements at centromeres

H. Niki, Keita Aoki, T. Nakagawa, 2020, Communications Biology.

SGX393 inhibits the CML mutant Bcr-AblT315I and preempts in vitro resistance when combined with nilotinib or dasatinib

Stephen K Burley, Sean Buchanan, Kevin Holme, 2008, Proceedings of the National Academy of Sciences.

SGX70393 inhibits the T315I mutant of Bcr-Abl kinase and pre-empts drug resistance when combined with nilotinib or dasatinib

S. Burley, A. Corbin, M. Deininger, 2007 .